{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:32:49Z","timestamp":1740144769660,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Toxicol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Fentanyl is an analgesic that is frequently prescribed, which resulted in non-intentional as well as intentional misuse and deaths. Here, we present a postmortem case of a patient who clearly died of a fentanyl overdose due to an extensive number of fentanyl patches combined with oral intake of fentanyl and cocaine. We aimed to show how postmortem analysis can be used to interpret postmortem fentanyl concentrations in unique cases like the one we present.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case description<\/jats:title>\n                <jats:p>A 23-year-old male was found dead in his bedroom with 67 non-prescribed patches of fentanyl on his body. In the room, there also were fentanyl tablets of 100\u00a0\u00b5g and cocaine powder, which had possibly also been taken by the deceased. To confirm the cause of death, urine and subclavian blood were retrieved to perform a standard postmortem toxicology screening. The toxicological screening revealed the presence of several drugs, including cocaine, fentanyl, lidocaine and paracetamol. Further analysis of the quantitative postmortem values of fentanyl with ultra-performance liquid chromatography-tandem mass spectrometry revealed a fentanyl concentration of 57.9\u00a0\u00b5g\/L. Considering several issues around postmortem drug analyses, this value seemed to be in line with concentrations found in previously reported postmortem cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We were able to confirm the expected cause of death with an extensive toxicological screening in combination with the circumstantial evidence. We identified fentanyl as most important cause for the fatal outcome in this specific case and simultaneously contributed to the limited availability of knowledge on postmortem fentanyl concentrations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11419-021-00598-3","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T22:20:15Z","timestamp":1633645215000},"page":"199-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report on postmortem fentanyl measurement after overdose with more than 67 fentanyl patches"],"prefix":"10.1007","volume":"40","author":[{"given":"L. E. J.","family":"Peeters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. T.","family":"Vleut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. E.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Croes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-2779","authenticated-orcid":false,"given":"C.","family":"Bethlehem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"598_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Ht S, Davis NL (2020) Drug and opioid-involved overdose deaths\u2014United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep 69:290\u2013297","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"598_CR2","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2165\/00003495-200161150-00014","volume":"61","author":"RBR Muijsers","year":"2001","unstructured":"Muijsers RBR, Wagstaff AJ (2001) Transdermal fentanyl. Drugs 61:2289\u20132307","journal-title":"Drugs"},{"key":"598_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.forsciint.2017.12.031","volume":"284","author":"CN Chatterton","year":"2018","unstructured":"Chatterton CN, Scott-Ham M (2018) The distribution and redistribution of fentanyl & norfentanyl in post mortem samples. Forensic Sci Int 284:146\u2013152","journal-title":"Forensic Sci Int"},{"key":"598_CR4","first-page":"1029","volume":"14","author":"I Solassol","year":"2005","unstructured":"Solassol I, Caumette L, Bressolle F, Garcia F, Thezenas S, Astre C, Culine S, Coulouma R, Pinguet F (2005) Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients. Oncol Rep 14:1029\u20131036","journal-title":"Oncol Rep"},{"key":"598_CR5","doi-asserted-by":"publisher","first-page":"109858","DOI":"10.1016\/j.forsciint.2019.06.016","volume":"302","author":"J Geile","year":"2019","unstructured":"Geile J, Maas A, Kraemer M, Doberentz E, Madea B (2019) Fatal misuse of transdermal fentanyl patches. Forensic Sci Int 302:109858","journal-title":"Forensic Sci Int"},{"key":"598_CR6","doi-asserted-by":"publisher","first-page":"bcr2016217231","DOI":"10.1136\/bcr-2016-217231","volume":"2017","author":"AJ Trist","year":"2017","unstructured":"Trist AJ, Sahota H, Williams L (2017) Not so patchy story of attempted suicide leading to 24 hours of deep sleep and survival! BMJ Case Rep 2017:bcr2016217231","journal-title":"BMJ Case Rep"},{"key":"598_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bcp.14135","volume":"86","author":"H Claridge","year":"2020","unstructured":"Claridge H, Williams BD, Copeland CS (2020) A deadly trend in fentanyl fatalities (England, 1998\u20132017). Br J Clin Pharmacol 86:437\u2013444","journal-title":"Br J Clin Pharmacol"},{"key":"598_CR8","doi-asserted-by":"publisher","first-page":"109896","DOI":"10.1016\/j.forsciint.2019.109896","volume":"302","author":"A Reiter","year":"2019","unstructured":"Reiter A, Mueller A, Otto B, Anders S, Falckenberg M, Iwersen-Bergmann S, Andresen-Streichert H (2019) Fast increase of postmortem fentanyl blood concentrations after transdermal application: a call to careful interpretation. Forensic Sci Int 302:109896","journal-title":"Forensic Sci Int"},{"key":"598_CR9","volume-title":"Targeted MRM screening for toxicants in biological samples by UPLC\/MS\/MS","author":"M Roberts","year":"2008","unstructured":"Roberts M, Lee R, Wood M (2008) Targeted MRM screening for toxicants in biological samples by UPLC\/MS\/MS. Waters Application Note, Wilmslow, UK"},{"key":"598_CR10","volume-title":"Systematic toxicological screening using the acquity UPLC I-class\/xevo TQ-S micro","author":"R Lee","year":"2016","unstructured":"Lee R, Wood M (2016) Systematic toxicological screening using the acquity UPLC I-class\/xevo TQ-S micro. Waters Application Note, Wilmslow, UK"},{"key":"598_CR11","doi-asserted-by":"publisher","first-page":"e4290","DOI":"10.1002\/bmc.4290","volume":"32","author":"RB Flint","year":"2018","unstructured":"Flint RB, Bahmany S, van der Nagel BCH, Koch BCP (2018) Simultaneous quantification of fentanyl, sufentanil, cefazolin, doxapram and keto-doxapram in plasma using liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 32:e4290","journal-title":"Biomed Chromatogr"},{"key":"598_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0379-0738(90)90182-X","volume":"45","author":"DJ Pounder","year":"1990","unstructured":"Pounder DJ, Jones GR (1990) Post-mortem drug redistribution\u2014a toxicological nightmare. Forensic Sci Int 45:253\u2013263","journal-title":"Forensic Sci Int"},{"key":"598_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1445-5994.2009.02111.x","volume":"40","author":"MC Kennedy","year":"2010","unstructured":"Kennedy MC (2010) Post-mortem drug concentrations. Int Med J 40:183\u2013187","journal-title":"Int Med J"},{"key":"598_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2125.2008.03231.x","volume":"66","author":"RE Ferner","year":"2008","unstructured":"Ferner RE (2008) Post-mortem clinical pharmacology. Br J Clin Pharmacol 66:430\u2013443","journal-title":"Br J Clin Pharmacol"},{"key":"598_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/PAF.0b013e318288b0d5","volume":"34","author":"DK Molina","year":"2013","unstructured":"Molina DK, Hargrove VM (2013) Should postmortem subclavian blood be considered a peripheral or central sample? Am J Forensic Med Pathol 34:155\u2013158","journal-title":"Am J Forensic Med Pathol"},{"key":"598_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/jat\/bks005","volume":"36","author":"H Andresen","year":"2012","unstructured":"Andresen H, Gullans A, Veselinovic M, Anders S, Schmoldt A, Iwersen-Bergmann S, Mueller A (2012) Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application. J Anal Toxicol 36:182\u2013194","journal-title":"J Anal Toxicol"},{"key":"598_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3109\/15563650.2010.525514","volume":"48","author":"RB Palmer","year":"2010","unstructured":"Palmer RB (2010) Fentanyl in postmortem forensic toxicology. Clin Toxicol (Phila) 48:771\u2013784","journal-title":"Clin Toxicol (Phila)"},{"key":"598_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/dta.2662","volume":"11","author":"RA Ketola","year":"2019","unstructured":"Ketola RA, Kriikku P (2019) Drug concentrations in post-mortem specimens. Drug Test Anal 11:1338\u20131357","journal-title":"Drug Test Anal"},{"unstructured":"Teva Pharma BV (2008) Fentanyl (Effentora) 100 mcg buccal tablets. In: Electronic medicines compendium. Haarlem, Netherlands","key":"598_CR19"},{"key":"598_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jcp.10078","volume":"191","author":"M Hummel","year":"2002","unstructured":"Hummel M, Unterwald EM (2002) D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action. J Cell Physiol 191:17\u201327","journal-title":"J Cell Physiol"},{"key":"598_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.forsciint.2010.03.032","volume":"200","author":"F Musshoff","year":"2010","unstructured":"Musshoff F, Madea B (2010) Cocaine and benzoylecgonine concentrations in fluorinated plasma samples of drivers under suspicion of driving under influence. Forensic Sci Int 200:67\u201372","journal-title":"Forensic Sci Int"},{"key":"598_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/jat\/19.7.554","volume":"19","author":"G Sloop","year":"1995","unstructured":"Sloop G, Hall M, Simmons GT, Robinson CA (1995) False-positive postmortem EMIT drugs-of-abuse assay due to lactate dehydrogenase and lactate in urine. J Anal Toxicol 19:554\u2013556","journal-title":"J Anal Toxicol"},{"key":"598_CR23","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/clinchem\/40.8.1594","volume":"40","author":"WC Thompson","year":"1994","unstructured":"Thompson WC, Malhotra D, Schammel DP, Blackwell W, Ward ME, Dasgupta A (1994) False-positive ethanol in clinical and postmortem sera by enzymatic assay: elimination of interference by measuring alcohol in protein-free ultrafiltrate. Clin Chem 40:1594\u20131595","journal-title":"Clin Chem"},{"key":"598_CR24","first-page":"23","volume":"222","author":"UO Wiesbrock","year":"2008","unstructured":"Wiesbrock UO, Rochholz G, Franzelius C, Schwark T, Grellner W (2008) Excessive use of fentanyl patches as the only means of suicide. Arch Kriminol 222:23\u201330","journal-title":"Arch Kriminol"},{"key":"598_CR25","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/1556-4029.14127","volume":"64","author":"A Nara","year":"2019","unstructured":"Nara A, Yamada C, Saka K, Kodama T, Yoshida M, Iwahara K, Takagi T (2019) A Fatal Case of Poisoning with Fentanyl Transdermal Patches in Japan. J Forensic Sci 64:1936\u20131942.","journal-title":"J Forensic Sci"},{"key":"598_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11419-013-0216-3","volume":"32","author":"DD Lung","year":"2014","unstructured":"Lung DD, Lemos NP (2014) Fentanyl: cause of death or incidental finding? Postmortem peripheral blood concentrations with and without documented transdermal patch use. Forensic Toxicol 32:118\u2013125.","journal-title":"Forensic Toxicol"}],"container-title":["Forensic Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-021-00598-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11419-021-00598-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-021-00598-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T18:28:11Z","timestamp":1641580091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11419-021-00598-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1007\/s11419-021-00598-3","relation":{},"ISSN":["1860-8965","1860-8973"],"issn-type":[{"type":"print","value":"1860-8965"},{"type":"electronic","value":"1860-8973"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"9 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The family gave consent for publication. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}